AU4858596A - Synthesis of quinazolinone libraries - Google Patents

Synthesis of quinazolinone libraries

Info

Publication number
AU4858596A
AU4858596A AU48585/96A AU4858596A AU4858596A AU 4858596 A AU4858596 A AU 4858596A AU 48585/96 A AU48585/96 A AU 48585/96A AU 4858596 A AU4858596 A AU 4858596A AU 4858596 A AU4858596 A AU 4858596A
Authority
AU
Australia
Prior art keywords
quinazolinone
libraries
synthesis
quinazolinone libraries
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU48585/96A
Inventor
Richard A. Houghten
John M Ostresh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Torrey Pines Institute for Molecular Studies
Original Assignee
Torrey Pines Institute for Molecular Studies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torrey Pines Institute for Molecular Studies filed Critical Torrey Pines Institute for Molecular Studies
Publication of AU4858596A publication Critical patent/AU4858596A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU48585/96A 1995-09-15 1996-01-18 Synthesis of quinazolinone libraries Abandoned AU4858596A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52940495A 1995-09-15 1995-09-15
US529404 1995-09-15
PCT/US1996/000886 WO1997010221A1 (en) 1995-09-15 1996-01-18 Synthesis of quinazolinone libraries

Publications (1)

Publication Number Publication Date
AU4858596A true AU4858596A (en) 1997-04-01

Family

ID=24109769

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48585/96A Abandoned AU4858596A (en) 1995-09-15 1996-01-18 Synthesis of quinazolinone libraries

Country Status (2)

Country Link
AU (1) AU4858596A (en)
WO (1) WO1997010221A1 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69842109D1 (en) * 1997-08-21 2011-03-10 Shiseido Co Ltd Quinazolin-4-one derivatives, their preparation and their use as hair restorers or in topical skin care products
US6417195B1 (en) 1999-02-22 2002-07-09 Lion Bioscience Ag Isoquinoline derivatives and isoquinoline combinatorial libraries
US6545004B1 (en) 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
US7230000B1 (en) 1999-10-27 2007-06-12 Cytokinetics, Incorporated Methods and compositions utilizing quinazolinones
US7671200B2 (en) 1999-10-27 2010-03-02 Cytokinetics, Inc. Quinazolinone KSP inhibitors
US20030119060A1 (en) 2001-08-10 2003-06-26 Desrosiers Peter J. Apparatuses and methods for creating and testing pre-formulations and systems for same
WO2003043995A1 (en) 2001-11-20 2003-05-30 Cytokinetics, Inc. Process for the racemization of chiral quinazolinones
ES2425476T3 (en) 2004-04-02 2013-10-15 Prana Biotechnology Limited Neurologically active compounds
WO2006045010A2 (en) 2004-10-20 2006-04-27 Resverlogix Corp. Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
EP1909788A2 (en) 2005-07-29 2008-04-16 Resverlogix Corp. Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
DK2118074T3 (en) 2007-02-01 2014-03-10 Resverlogix Corp Compounds for the prevention and treatment of cardiovascular diseases
RU2520098C2 (en) 2008-06-26 2014-06-20 Ресверлоджикс Корп. Method of producing quinazolinone derivatives
JP5635535B2 (en) 2009-01-08 2014-12-03 レスバーロジックス コーポレイション Compounds for the prevention and treatment of cardiovascular disease
CA2992231C (en) 2009-03-18 2022-03-29 Resverlogix Corp. Phenyl-quinazolin-4(3h)-one and phenyl-pyrido[2,3-d]pyrimidin-4(3h)-one derivatives and compositions thereof useful as anti-inflammatory agents
KR20190091564A (en) 2009-04-22 2019-08-06 리스버로직스 코퍼레이션 Novel anti-inflammatory agents
AU2011298423B2 (en) 2010-09-03 2015-11-05 Bayer Intellectual Property Gmbh Substituted fused pyrimidinones and dihydropyrimidinones
CN103945848B (en) 2011-11-01 2016-09-07 雷斯韦洛吉克斯公司 The oral immediate release formulations of the quinazolinone being replaced
US8940742B2 (en) 2012-04-10 2015-01-27 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
WO2014080291A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Biaryl derivatives as bromodomain inhibitors
WO2014080290A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Cyclic amines as bromodomain inhibitors
CA2895905A1 (en) 2012-12-21 2014-06-26 Zenith Epigenetics Corp. Novel heterocyclic compounds as bromodomain inhibitors
US9751888B2 (en) 2013-10-04 2017-09-05 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
PL3052485T3 (en) 2013-10-04 2022-02-28 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
SG11201607705XA (en) 2014-03-19 2016-10-28 Infinity Pharmaceuticals Inc Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
US9708348B2 (en) 2014-10-03 2017-07-18 Infinity Pharmaceuticals, Inc. Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof
KR102662814B1 (en) 2015-03-13 2024-05-03 리스버로직스 코퍼레이션 Compositions and treatment methods for treating complement-related diseases
WO2017003723A1 (en) 2015-07-01 2017-01-05 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
US10160761B2 (en) 2015-09-14 2018-12-25 Infinity Pharmaceuticals, Inc. Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the same
WO2017161116A1 (en) 2016-03-17 2017-09-21 Infinity Pharmaceuticals, Inc. Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
US10919914B2 (en) 2016-06-08 2021-02-16 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
WO2019023278A1 (en) 2017-07-25 2019-01-31 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
KR101964810B1 (en) * 2017-10-12 2019-04-02 충북대학교 산학협력단 Novel N-Hydroxybenzamides or N-Hydroxypropenamides Incorporating Quinazolin-4(3H)-ones as Histone Deacetylase Inhibitors and Anticancer Composition Comprising the Same
CN113754594A (en) * 2021-09-16 2021-12-07 中国药科大学 Quinazolinone compound or pharmaceutically acceptable salt and isomer thereof, preparation method, pharmaceutical composition and application thereof
CN115044276B (en) * 2022-07-22 2023-05-19 山东佰盛能源科技有限公司 Pipeline anti-corrosion coating and production process thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2786055A (en) * 1955-02-10 1957-03-19 Mallinckrodt Chemical Works Carboxyalkyl-iodoquinazolones
GB982207A (en) * 1961-12-22 1965-02-03 Orgamol Sa Process for the production of quinazolone derivatives
DE1249281B (en) * 1963-05-18
DE1229094B (en) * 1964-02-21 1966-11-24 Boehringer Sohn Ingelheim Process for the preparation of new 2-methyl-3-phenyl-quinazolone- (4) -derivatives
DE1670416A1 (en) * 1966-12-30 1971-02-11 Chem Fab Von Heyden Gmbh Muenc Process for the preparation of amino-substituted quinazolinone derivatives
DE1670497C3 (en) * 1967-06-06 1973-12-20 Chinoin Gyogyszer- Es Vegyeszeti Termekek Gyara Rt, Budapest Isoquinone derivatives and process for their preparation
US3696102A (en) * 1970-03-09 1972-10-03 Pfizer & Co C Process for the synthesis of substituted quinazolin-4-ones
DE2020234A1 (en) * 1970-04-25 1971-11-18 Cassella Farbwerke Mainkur Ag Basically substituted derivatives of 4 (3H) -quinazolinone
JPS5442991B2 (en) * 1972-06-12 1979-12-17
GB1466571A (en) * 1973-10-23 1977-03-09 Roussel Lab Substituted quinazolone compounds and pharmaceutical uses thereof
WO1992013535A1 (en) * 1991-02-06 1992-08-20 Research Corporation Technologies, Inc. Anticonvulsant substituted quinazolones

Also Published As

Publication number Publication date
WO1997010221A1 (en) 1997-03-20

Similar Documents

Publication Publication Date Title
AU4858596A (en) Synthesis of quinazolinone libraries
AU4416497A (en) Synthesis of quinazolinone libraries and derivatives thereof
AU8256098A (en) Systems and methods for parallel synthesis of compounds
AU2657095A (en) Synthesis of oligonucleotides
PL323066A1 (en) Derivatives of quinazoline
PL313541A1 (en) Derivatives of quinazoline
AU6231196A (en) Speech synthesis
AU5159696A (en) Waveform speech synthesis
AU8589798A (en) Selective synthesis of organodiphosphite compounds
AU9785098A (en) Synthesis of sapo-44
GB9513515D0 (en) Expansion of data
HUP9800849A3 (en) Improved synthesis of cyclopropylacetylene
AU5871196A (en) Methods and compounds for the synthesis of oligonucleotides and the oligonucleotides thereby produced
AU5381696A (en) Synthesis of bis-indolylmaleimides
AU7129098A (en) Synthesis and use of alpha-ketoamide derivatives and arrays
AU2217797A (en) Synthesis of indolylmaleimides
AU7312196A (en) Synthesis of polymerisable phosphodiesters
AU4157097A (en) Synthesis of bisindolylmalimides
AU4224096A (en) Use of phenylcyclohexylcarboxamides
EP0827506A4 (en) Synthesis of glycopolymers
AU1089599A (en) Synthesis of azetidine derivatives
AU5629096A (en) Synthesis of difluoromethane
AU4633397A (en) Synthesis of phosphorus compounds
AU4877196A (en) Derivatives of 3-pyrrolidylidene-2-one-cephalosporines
IL113228A (en) Derivatives of anandamide